Washington CORE Summer Research Intern, Yunho Lee, a student at Yonsei University of South Korea, recently delivered a presentation on South Korea’s biopharma industry. He highlighted the nation’s ambition to become a global leader by 2030. Yunho detailed the industry’s growth, featuring major players like Samsung Biologics, Celltrion Pharmaceuticals, and Yuhan Corporation. He also discussed government programs to promote Korea’s clinical research organization (CRO) industry, including CRO certification and export activation strategies. Yunho emphasized recent developments including international collaboration efforts by trade organizations like the Korea Biotechnology Industry Organization (Korea Bio). His insights underscored South Korea’s significant strides in biopharma and its strategic initiatives to advance globally.